Latest Articles

Publication Date
GLP-1–Progestin and Endometrial Cancer Risk - Conexiant

GLP-1–Progestin and Endometrial Cancer Risk Conexiant

Published: March 2, 2026, 5:01 p.m.
Changing the paradigm of endometriosis - from diagnosis to integrated long-term management: a joint society opinion paper.

Endometriosis is a chronic, systemic, oestrogen-dependent disease with major impacts on pain, fertility and quality of life. This Society of Endometriosis and Uterine Disorders and American Institute for Minimally Invasive …

Published: Feb. 24, 2026, midnight
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... - Medical Dialogues

Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues

Published: Feb. 17, 2026, 3:15 p.m.
Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk - geneonline.com

Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk geneonline.com

Published: Feb. 16, 2026, 6:10 a.m.
Study Finds GLP-1 Agonists Combined with Progestin Reduce Endometrial Cancer Risk by 66% - geneonline.com

Study Finds GLP-1 Agonists Combined with Progestin Reduce Endometrial Cancer Risk by 66% geneonline.com

Published: Feb. 16, 2026, 5:37 a.m.
Dydrogesterone and Letrozole Combination for the Treatment of Endometriosis: A Mechanism-Based Therapeutic Approach.

Endometriosis is a complex, estrogen-dependent disease with limited effective treatments that often focus on symptom management rather than addressing the underlying pathology. Current therapies, such as progestins and GnRH agonists, …

Published: Feb. 13, 2026, midnight
Impact of hormonal treatments for endometriosis on the reproductive microbiome: a systematic review.

The reproductive microbiome plays a key role in disease progression and fertility in women with endometriosis. Vaginal and endometrial dysbiosis has been increasingly linked to inflammation, impaired reproductive outcomes, and …

Published: Feb. 12, 2026, midnight
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk - Medscape

GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk Medscape

Published: Feb. 11, 2026, 8:49 a.m.
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on - Bioengineer.org

GLP-1 Receptor Agonists Combined with Progestins and Their Impact on Bioengineer.org

Published: Feb. 10, 2026, 6:37 p.m.
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on - BIOENGINEER.ORG

GLP-1 Receptor Agonists Combined with Progestins and Their Impact on BIOENGINEER.ORG

Published: Feb. 10, 2026, 6:37 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!